Significance of complement split product C4d in ABO-compatible liver allograft: Diagnosing utility in acute antibody mediated rejection

Transplant Immunology

Volumn 26, Issue 1, 2012, Pages 62-69

  Ali, Sharif ^a   Ormsby, Adrian ^b   Shah, Veena ^b   Segovia, Maria C ^c   Kantz, Kristin L ^b   Skorupski, Sharon ^b   Eisenbrey, A Bradley ^b   Mahan, Meredith ^a   Huang, Mary Ann Y ^c  

^a HENRY FORD HOSPITAL   (United States)

^b Division of Surgical Pathology ^*  (United States)

^c Division of Gastroenterology/Transplant Hepatology   (United States)

Author keywords

ABO compatible liver transplantation; Antibody mediated rejection; C4d

Indexed keywords

COMPLEMENT; COMPLEMENT DEGRADATION PRODUCT 4D; UNCLASSIFIED DRUG;

ABO COMPATIBLE LIVER TRANSPLANTATION; ACUTE ANTIBODY MEDIATED REJECTION; ADULT; ALCOHOLIC FATTY LIVER; ANTIBODY SCREENING; ARTICLE; AUTOIMMUNE HEPATITIS; BILIARY TRACT DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FLOW CYTOMETRY; GRAFT FAILURE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HLA TYPING; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER NECROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY;

ABO BLOOD-GROUP SYSTEM; BIOLOGICAL MARKERS; COMPLEMENT C4B; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HISTOCYTOCHEMISTRY; HUMANS; ISOANTIBODIES; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; RETROSPECTIVE STUDIES; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 82955237624     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2011.08.005     Document Type: Article

References (29)

1. Cecka J.M. The changing role of HLA matching. Clin Transpl 1986, 141-155.
2. Opelz G. Correlation of HLA matching with kidney graft survival in patients with or without cyclosporine treatment. Transplantation Sep 1985, 40(3):240-243.
3. Hadjiliadis D., Chaparro C., Reinsmoen N.L., et al. Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study. J Heart Lung Transplant Jul 2005, 24(7 Suppl):S249-S254.
4. Navarro V., Herrine S., Katopes C., Colombe B., Spain C.V. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database. Liver Transpl Apr 2006, 12(4):652-658.
5. Neumann U.P., Guckelberger O., Langrehr J.M., et al. Impact of human leukocyte antigen matching in liver transplantation. Transplantation 2003, 75(1):132-137.
6. Olausson M., Mjornstedt L., Norden G., et al. Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients. Am J Transplant Jan 2007, 7(1):130-136.
7. Mosconi G., Scolari M.P., Feliciangeli G., et al. Combined liver-kidney transplantation with preformed anti-HLA antibodies: a case report. Transplant Proc May 2006, 38(4):1125-1126.
8. Martin T., Schwartz J., Demetris A., Comstock J., Lowichik A., Book L. Plasmapheresis treatment of antibody-mediated rejection in an A2 donor to O pediatric liver transplant recipient. Pediatr Transplant 2011 Feb, 15(1):E15-18. doi:10.1111/j.1399-3046.2009.01224.x.
9. Watson R., Kozlowski T., Nickeleit V., et al. Isolated donor specific alloantibody-mediated rejection after ABO compatible liver transplantation. Am J Transplant Dec 2006, 6(12):3022-3029.
10. Kamar N., Lavayssiere L., Muscari F., et al. Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation. World J Gastroenterol 2009, 15(27):3426-3430.
11. Rostron A., Carter V., Mutunga M., et al. A case of acute humoral rejection in liver transplantation: successful treatment with plasmapheresis and mycophenolate mofetil. Transpl Int Nov 2005, 18(11):1298-1301.
12. Takemoto S.K., Zeevi A., Feng S., et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant Jul 2004, 4(7):1033-1041.
13. Sis B., Mengel M., Haas M., et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010 Mar, 10(3):464-471.
14. Behr T.M., Feucht H.E., Richter K., et al. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant Sep 1999, 18(9):904-912.
15. Collins A.B., Schneeberger E.E., Pascual M.A., et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol Oct. 1999, 10(10):2208-2214.
16. Magro C.M., Pope Harman A., Klinger D., et al. Use of C4d as a diagnostic adjunct in lung allograft biopsies. Am J Transplant Sep. 2003, 3(9):1143-1154.
17. Haga H., Egawa H., Shirase T., et al. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation. Liver Transpl Jan. 2004, 10(1):16-27.
18. Morioka D., Sekido H., Kubota K., et al. Antibody-mediated rejection after adult ABO-incompatible liver transplantation remedied by gamma-globulin bolus infusion combined with plasmapheresis. Transplantation 2004, 78(8):1225-1228.
19. Demetris A.J., Jaffe R., Tzakis A., et al. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol Sep. 1988, 132(3):489-502.
20. Ali S.A., Shah V., McKinnon R., Van Harn M., Janakiraman N. Frequent expression of C4d in hepatic graft-versus-host disease: potential clue for diagnosis and distinguishing acute and chronic form. Transpl Immunol May 2010, 23(1-2):77-80.
21. Haga H., Egawa H., Fujimoto Y., et al. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation. Liver Transpl Mar 2006, 12(3):457-464.
22. Demetris A.J., Murase N., Nakamura K., et al. Immunopathology of antibodies as effectors of orthotopic liver allograft rejection. Semin Liver Dis Feb 1992, 12(1):51-59.
23. McMillan R.W., Gelder F.B., Zibari G.B., Aultman D.F., Adamashvili I., McDonald J.C. Soluble fraction of class I human histocompatibility leukocyte antigens in the serum of liver transplant recipients. Clin Transplant Apr. 1997, 11(2):98-103.
24. Davies H.S., Pollard S.G., Calne R.Y. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation Mar. 1989, 47(3):524-527.
25. Musat A.I., Agni R.M., Wai P.Y., et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant Mar. 2011, 11(3):500-510.
26. Kozlowski T., Rubinas T., Nickeleit V., et al. Liver allograft antibody mediated rejection with demonstration of sinusoidal C4d staining and circulating donor specific antibodies. Liver Transpl 2011, 17(4):357-368.
27. Sakashita H., Haga H., Ashihara E., et al. Significance of C4d staining in ABO-identical/compatible liver transplantation. Mod Pathol 2007, 20(6):676-684.
28. Bouron-Dal Soglio D., Rougemont A.L., Herzog D., Soucy G., Alvarez F., Fournet J.C. An immunohistochemical evaluation of C4d deposition in pediatric inflammatory liver diseases. Hum Pathol 2008, 39(7):1103-1110.
29. Schmeding M., Dankof A., Krenn V., et al. C4d in acute rejection after liver transplantation-a valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transplant 2006, 6(3):523-530.